Document:

EX-10.2

 Exhibit 10.2 

SUPPORT AGREEMENT 
 This
Support Agreement, dated as of October 13, 2022 (this “Agreement”), is made and entered into by and among the Company, a Delaware corporation (the “Company”), and Stockholder,
(“Stockholder” and, together with the Company, the “Parties”). 
 RECITALS 

WHEREAS, as of the date hereof, Stockholder is the beneficial owner (as defined in Rule 13d-3
under the Exchange Act) of 145,319,800 shares of Class A Common Stock, par value $0.01 per share (the “Common Stock”), of the Company, (all such shares collectively, the “Subject Shares”); 

WHEREAS, concurrently with the execution hereof, The Kroger Co., an Ohio Corporation (“Parent”), Kettle Merger Sub,
Inc., a Delaware corporation and a direct, wholly owned Subsidiary of Parent (“Merger Sub”), and the Company are entering into an Agreement and Plan of Merger, dated as of the date hereof (as it may be amended from time to
time, excluding any Prohibited Amendment (as defined below), the “Merger Agreement”), which provides for, among other things, at the Effective Time, the merger of Merger Sub with and into the Company (the
“Merger”), upon the terms and subject to the conditions set forth in the Merger Agreement (capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger
Agreement); and 
 WHEREAS, as a condition to their willingness to enter into the Merger Agreement, Parent and Merger Sub have required that
Stockholder, and as an inducement and in consideration therefor, Stockholder (in Stockholder’s capacity as the beneficial owner of the Subject Shares) has agreed to, enter into this Agreement. 

NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth below and
for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto, intending to be legally bound, do hereby agree as follows: 

ARTICLE I 
 AGREEMENT 

1.1    Agreement. Upon the terms and subject to the conditions of this Agreement, Stockholder hereby undertakes and
agrees that, unless and until this Agreement shall have been validly terminated in accordance with Section 5.2, Stockholder shall (or, to the extent that any of the Subject Shares are held of record by another record holder on behalf of
Stockholder (a “Record Holder”), shall cause such Record Holder and any other Person through which any of the Subject Shares are directly or indirectly beneficially owned by or held on behalf of the Stockholder (each, an
“Intermediary”) to) execute, deliver and take (or permit another Person to execute, deliver and take), pursuant to Section 228 of the DGCL, an action by consent in lieu of a meeting of stockholders of the Company
approving and adopting the Merger Agreement and the transactions contemplated thereby as promptly as practicable (and in any event four (4) Business Days following execution and delivery of this Agreement). Without limiting the foregoing, upon
the terms and subject to the conditions of this Agreement and unless and until this Agreement shall 

 
have been validly terminated in accordance with Section 5.2, to the extent that any of the Subject Shares are held by another Record Holder, Stockholder shall, as promptly as practicable
(and in any event within four (4) Business Days following execution and delivery of this Agreement): (i) direct such Record Holder (and direct any applicable Intermediaries to direct such Record Holder) to execute, deliver and take an action by
consent in lieu of a meeting of stockholders of the Company approving and adopting the Merger Agreement and the transactions contemplated thereby, and to provide any and all applicable directions and instructions to any such Record Holders and
Intermediaries with respect thereto and/or (ii) obtain a proxy, power of attorney, or similar authority from any such Record Holders authorizing Stockholder to execute, deliver and take an action by consent in lieu of a meeting of stockholders
of the Company approving and adopting the Merger Agreement and the transactions contemplated thereby and thereupon execute, deliver and take such action by consent pursuant to such proxy or power of attorney. 

1.2    Power of Attorney. To secure the Stockholder’s obligations in accordance with Section 1.1 of this
Agreement, the Stockholder hereby grants Juliette W. Pryor, Executive Vice President, General Counsel and Secretary of the Company, as the Stockholder’s attorney in fact, with the power to act alone, to execute all appropriate instruments
consistent with this Agreement on behalf of the Stockholder if, and only if, the Stockholder fails to execute such other instruments in accordance with the provisions of this Agreement within four (4) Business Days following execution and
delivery of this Agreement. Such appointment will be irrevocable for the term hereof. The appointment will survive the merger or reorganization of the Stockholder. 

ARTICLE II 
 REPRESENTATIONS AND
WARRANTIES OF STOCKHOLDER 
 Stockholder represents and warrants to the Company that: 

2.1    Organization; Authorization; Binding Agreement. To the extent that Stockholder is an entity, Stockholder is
duly organized and validly existing under the laws of the jurisdiction of its formation or incorporation and Stockholder has duly authorized its execution, delivery and performance of this Agreement. Stockholder has full power and authority to
execute, deliver and perform this Agreement. This Agreement has been duly and validly executed and delivered by Stockholder, and constitutes a legal, valid and binding obligation of Stockholder enforceable against Stockholder in accordance with its
terms (except insofar as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or other Laws of general applicability relating to or affecting creditors’ rights, or by principles governing the availability of
equitable remedies, whether considered in a Proceeding at law or in equity). 

2.2    Non-Contravention. The execution and delivery of this Agreement by
Stockholder does not, and the performance by Stockholder of Stockholder’s obligations hereunder and the consummation by Stockholder of the transactions contemplated hereby will not, (a) conflict with, or result in any violation or breach
of, any Law applicable to Stockholder or Stockholder’s Subject Shares and, to the extent that such Stockholder is an entity, the organizational or governing documents of such Stockholder, or (b) except as may be required by applicable
securities Laws, require any consent, approval, order, authorization or other action by, or filing with or notice to, any Person (including any Governmental Entity) under any applicable Law, in case of each of clauses (a) and (b), except as
would not reasonably be expected to have a material adverse effect on Stockholder’s ability to timely perform its obligations under this Agreement. 

  
 2 

 2.3    Ownership of Subject Shares. Stockholder is the beneficial
owner (as defined in Rule 13d-3 under the Exchange Act) of Stockholder’s Subject Shares. The Subject Shares constitute all of the shares of Common Stock owned by Stockholder over which Stockholder has
sole voting and disposition authority, beneficially or of record, as of the date hereof, subject to this Agreement, any agreement of the Stockholder, any Intermediary or any of their respective Affiliates for any borrowed money, advance or extension
of credit or the pledge, hypothecation or other granting of a security interest in any Subject Shares to one or more banks or financial institutions as bona fide collateral or security for any such loan, advance or extension of credit (each
such agreement, a “Loan Agreement”) and the Filed Company SEC Documents. 
 2.4    Voting
Power. Subject to this Agreement, any Loan Agreement and the Filed Company SEC Documents, Stockholder has full and sole power and authority to direct the voting of, and full and sole power of disposition with respect to, all of the Subject
Shares. Other than any Loan Agreement or Filed Company SEC Document, none of the Subject Shares are subject to any stockholders’ agreement, proxy, voting trust or other agreement or arrangement with respect to the voting of the Subject Shares
with respect to the Merger Agreement, except as provided hereunder. 
 ARTICLE III 

REPRESENTATIONS AND WARRANTIES OF THE COMPANY 

The Company represents and warrants to Stockholder that: 

3.1    Organization; Authorization. The Company is duly organized and validly existing and in good standing under
the laws of the jurisdiction in which it is organized (in the case of good standing, to the extent the concept is recognized by such jurisdiction). The consummation of the transactions contemplated hereby are within the Company’s corporate
powers and have been duly authorized by all necessary corporate action on the part of the Company. The Company has all requisite corporate power and authority to execute and deliver this Agreement and to consummate the transactions contemplated
thereby. 
 3.2    Binding Agreement. The Company has duly executed and delivered this Agreement, and this
Agreement constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms (except insofar as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or
other Laws of general applicability relating to or affecting creditors’ rights, or by principles governing the availability of equitable remedies, whether considered in a Proceeding at law or in equity). 

3.3    No Other Representations. The Company hereby acknowledges and agrees that, except for the representations
and warranties of Stockholder expressly set in Article II of this Agreement, none of Stockholder, its Affiliates, any Representative of any of the foregoing or any other Person has made, and neither the Company or any other Person has relied on, any
representation or warranty regarding the Stockholder, the sufficiency of the representations and warranties set forth herein or any other matter in connection with the entry by Stockholder into this Agreement. 

  
 3 

 ARTICLE IV 

ADDITIONAL COVENANTS OF STOCKHOLDER 

4.1    No Transfer; No Inconsistent Arrangements. Except as provided hereunder or under the Merger Agreement, any
Loan Agreement or any Filed Company SEC Document, from and after the date hereof and until the termination of this Agreement in accordance with Section 5.2, Stockholder shall not, directly or indirectly, (a) create any
Lien on any or all of Stockholder’s Subject Shares, except for any Liens existing on the date of this Agreement, (b) transfer, sell, assign, gift, exchange, tender, hypothecate or otherwise dispose of (collectively,
“Transfer”) any of Stockholder’s Subject Shares, (c) grant or permit the grant of any proxy or power of attorney with respect to any of Stockholder’s Subject Shares to the extent inconsistent with such
Stockholder’s obligations hereunder, or (d) deposit or permit the deposit of any of Stockholder’s Subject Shares into a voting trust or enter into a voting agreement or arrangement with respect to any of such Stockholder’s
Subject Shares, in each case except as may be necessary or advisable in connection with Stockholder’s performance of its obligations hereunder. 

4.2    Adjustments. In the event of any stock split, stock dividend, merger, reorganization, recapitalization,
reclassification, combination, exchange of shares or similar transaction with respect to the capital stock of the Company that affects the Subject Shares, the terms of this Agreement shall apply to the resulting securities. 

ARTICLE V 
 MISCELLANEOUS 

5.1    Notices. All notices and other communications hereunder shall be in writing and shall be deemed given
(a) when delivered personally by hand (with written confirmation of receipt), (b) when sent by email (provided that no “bounce-back” or similar notice is received by the electronic mail sender within two (2) hours thereafter
indicating that such electronic mail was undeliverable or otherwise not delivered)) or (c) one (1) Business Day following the day sent by an internationally recognized overnight courier (with written confirmation of receipt), in each case, at
the following addresses and email addresses (or to such other address or email address as a Party may have specified by notice given to the other Party under this provision): (i) if to the Company, in accordance with the provisions of the Merger
Agreement and (ii) if to Stockholder, to Stockholder’s address or e-mail address set forth on a signature page hereto, or to such other address or e-mail
address as Stockholder may hereafter specify in writing for the purpose by notice to the Company. 

5.2    Termination. This Agreement shall terminate automatically as to Stockholder and the Company, without any
notice or other action by any Person, upon the first to occur of (a) the valid termination of the Merger Agreement in accordance with its terms, (b) the Effective Time, (c) the date of any Prohibited Amendment that is effected without
Stockholder’s prior written consent, (d) the extension of the Outside Date, without the prior written consent of Stockholder, (e) delivery of a Common Stockholder Written Consent from the Record Holder, (f) the adoption of the
Merger Agreement by the holders of a majority of votes represented by the outstanding shares of Common Stock or (g) the written consent of Stockholder and the Company. Upon termination of this Agreement as to any Party, such Party shall not
have any further obligations or liabilities under this Agreement; provided, however, that the provisions of this Article V shall 

  
 4 

 
survive any termination of this Agreement. A “Prohibited Amendment” means any one or more amendments, modifications or waivers of any provision of the Merger Agreement (as
in effect on the date hereof) in a manner that reduces the amount of the Merger Consideration (including any change to the formula with respect thereto), changes the form of the Merger Consideration payable, imposes any material restrictions on or
additional material conditions on the payment of the Merger Consideration, modifies any of the provisions relating to the payment of dividends (including the Pre-Closing Common Dividend), Company Change in
Recommendation, SpinCo, the SpinCo Consideration, the Separation, the Company Termination Fee, the Parent Termination Fee or Antitrust Law, extends the Outside Date or otherwise adversely affects the Record Holder (in its capacity as such) in any
material respect. 
 5.3    Amendments and Waivers. Any provision of this Agreement may be amended or waived if
such amendment or waiver is in writing and is signed, in the case of an amendment, by each Party to this Agreement or, in the case of a waiver, by each Party against whom the waiver is to be effective. No failure or delay by any Party in exercising
any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. 

5.4    Expenses. All fees and expenses incurred in connection herewith and the transactions contemplated hereby
shall be paid the Party incurring such fees or expenses, whether or not the Merger is consummated. 
 5.5    Binding
Effect; Benefit; Assignment. Except as otherwise expressly provided herein, the Parties hereby agree that their respective representations, warranties and covenants set forth herein are solely for the benefit of the other Party, in accordance
with and subject to the terms of this Agreement, and this Agreement is not intended to, and does not, confer upon any Person (including, for the avoidance of doubt, Parent, Merger Sub, and their respective Affiliates and Representatives) other than
the Parties hereto any rights or remedies hereunder, including the right to rely upon the representations and warranties set forth herein, except as provided in Section 5.16 (which will be to the benefit of the Persons
referred to in such Section). Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any of the Parties (whether by operation of Law or otherwise) without the prior written consent of the other Party.
No assignment by any Party shall relieve such Party of any of its obligations hereunder. Subject to the limitations regarding assignment herein, this Agreement will be binding upon, inure to the benefit of and be enforceable by the Parties and their
respective successors and permitted assigns. Any purported assignment not permitted under this Section 5.5 shall be null and void ab initio. 

5.6    Governing Law; Venue. This Agreement, and all actions and causes of action (whether in contract or in tort
or otherwise, or whether at law (including at common law or by statute) or in equity), that may be based on this Agreement, arise out of this Agreement or relate hereto or the negotiation, execution, performance or subject matter hereof, shall be
governed by the Laws of the State of Delaware applicable to agreements made and to be performed solely therein, without giving effect to principles of conflicts of law. For any Action or cause of action that may be based on this Agreement, arise out
of this Agreement or relate hereto or the negotiation, execution, performance or subject matter hereof, each Party hereto (a) irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the Court of Chancery
of the State of Delaware or, to the extent such court does not have subject matter 

  
 5 

 
jurisdiction, the U.S. District Court for the District of Delaware or, to the extent such court does not have subject matter jurisdiction, the Superior Court of the State of Delaware,
(b) agrees that all such Actions and causes of action shall be heard and determined exclusively under the foregoing clause (a), (c) waives any objection to laying venue in any such Actions or cause of action in such courts, (d) waives any
objection that any such court is an inconvenient forum or does not have jurisdiction over any Party hereto and (e) agrees that service of process upon such Party in any such Action or cause of action shall be effective if such process is given
as a notice under Section 5.1. EACH PARTY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION OR CAUSE OF ACTION THAT MAY BE BASED ON THIS AGREEMENT, ARISE OUT OF THIS AGREEMENT OR RELATE HERETO OR THE
NEGOTIATION, EXECUTION, PERFORMANCE OR SUBJECT MATTER HEREOF. EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY
HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT. EACH PARTY HERETO CERTIFIES AND ACKNOWLEDGES THAT
(I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HERETO HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY HERETO WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (II) SUCH PARTY
UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER; (III) SUCH PARTY MAKES THE FOREGOING WAIVER VOLUNTARILY AND (IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER
AND CERTIFICATIONS IN THIS SECTION 5.6. 
 5.7    Enforcement of Agreement. The Company agrees that its
sole and exclusive remedy for any action or cause of action (whether in contract or in tort or otherwise, or whether at law (including at common law or by statute) or in equity), that may be based on this Agreement, arise out of this Agreement or
relate hereto or the negotiation, execution, performance or subject matter hereof, shall be an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof. It is accordingly agreed that
the Parties shall be entitled to an injunction or injunctions, or any other appropriate form of specific performance or equitable relief, to prevent breaches or threatened breaches of this Agreement and to enforce specifically the terms and
provisions of this Agreement in any court to which the Parties have submitted under Section 5.6. 

5.8    Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed an
original and all of which shall be one (1) and the same instrument. Delivery of an executed counterpart hereof by facsimile or other electronic transmission (including email or any electronic signature complying with the U.S. federal ESIGN Act
of 2000, e.g., www.docusign.com) shall be effective as delivery of an original counterpart hereof. 

5.9    Entire Agreement. This Agreement, together with the other documents and instruments referred to herein,
constitute the entire agreement, and supersede all prior agreements and understandings, both written and oral, among the Parties hereto and their Affiliates, or any of them, related to the subject matter hereof. 

  
 6 

 5.10    Severability. If any term or other provision of this
Agreement is determined by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced by any rule or law, or public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force
and effect. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as
closely as possible in an acceptable manner to the end that transactions contemplated hereby are fulfilled to the extent possible. 

5.11    Headings. The Section headings contained in this Agreement are for reference purposes only and shall not
affect in any way the meaning or interpretation of this Agreement. 
 5.12    Interpretation. Unless the context
otherwise requires, as used in this Agreement: (a) “or” is not exclusive; (b) “including” and its variants mean “including, without limitation” and its variants; (c) words defined in the singular have the parallel
meaning in the plural and vice versa; (d) words of one gender shall be construed to apply to each gender; and (e) the terms “Article,” “Section” and “Schedule” refer to the specified Article, Section or
Schedule of or to this Agreement; and (f) neither the Company nor any of its Subsidiaries shall be construed to be a Subsidiary or Affiliate of Stockholder. 

5.13    Capacity as Stockholder. Notwithstanding anything herein to the contrary, (a) Stockholder signs this
Agreement solely in Stockholder’s capacity as a beneficial owner of the Subject Shares, and not in any other capacity and this Agreement shall not limit or otherwise affect the actions of Stockholder, any Affiliate thereof or any of their
respective Representatives or designees in its capacity, if applicable, as an officer, director, employee or agent of the Company, and (b) nothing herein shall in any way restrict a director, officer, employee or agent of the Company in the
taking of any actions (or failure to act) in his or her capacity as such, or in the exercise of his or her fiduciary duties as a director or officer of the Company or otherwise, or prevent or be construed to create any obligation on the part of any
director, officer, employee or agent of the Company from taking any action in his or her capacity as such. 

5.14    No Agreement Until Executed. This Agreement shall not be effective unless and until (a) the Merger
Agreement is executed by all parties thereto, and (b) this Agreement is executed by all Parties hereto. 

5.15    No Ownership Interest. Nothing contained in this Agreement shall be deemed to vest in the Company or any
other Person any direct or indirect ownership or incidence of ownership of or with respect to the Subject Shares. All rights, ownership and economic benefits of and relating to the Subject Shares shall remain vested in and belong to Stockholder, and
the Company shall not exercise any power or authority to direct Stockholder in the voting of any of the Subject Shares, except as otherwise expressly provided herein. 

5.16    Non-Recourse. Notwithstanding anything that may be expressed or
implied in this Agreement, or any document, certificate or instrument delivered in connection herewith or otherwise (together, the “Transaction Documents”), the Company acknowledges and agrees, on behalf of itself and its
respective Related Persons (as defined below), that all Proceedings that may be based upon, in respect of, arise under, out of, by reason of, be connected with, or relate in any 

  
 7 

 
manner to (a) this Agreement or any Transaction Document or the Transactions, (b) the negotiation, execution or performance of this Agreement or any other Transaction Document
(including any representation or warranty made in, in connection with, or as an inducement to, any of the foregoing documents), (c) any breach or violation of this Agreement or any other Transaction Document or (d) the failure of the
Transactions to be consummated, in each case may be made only against (and are those solely of) the Persons that are expressly identified Parties hereto. In furtherance and not in limitation of the foregoing, the Company acknowledges and agrees, on
behalf of itself and its respective Related Persons, that no recourse under this Agreement or any other Transaction Document or in connection with any Transactions shall be sought or had against any such other Person and no such other Person shall
have any liabilities (whether in contract or in tort, in law or in equity or otherwise, or granted by statute or otherwise, whether by or through attempted piercing of the corporate, partnership, limited partnership or limited liability company veil
or any other theory or doctrine) of any nature whatsoever arising under, out of, in connection with or related in any manner to the items in the preceding clauses (a) through (d), it being expressly agreed and acknowledged that no liabilities
whatsoever shall attach to, be imposed on or otherwise be incurred by any direct or indirect, past, present or future shareholder, equity holder, controlling person, member, partner (limited or general), manager, director, officer, employee, lender,
financing source, Affiliate, agent or other representative of Stockholder or any Affiliate of Stockholder (collectively, with such Person’s assignees, successors and assigns, the “Related Persons”), through the Company,
its Subsidiaries or otherwise, whether by or through attempted piercing of the corporate, partnership, limited partnership or limited liability company veil, by or through a claim by or on behalf of any party hereto, as applicable, by the
enforcement of any assessment or by any legal or equitable actions, suits, claims, investigations or proceedings, by virtue of any Law, or otherwise. The Parties acknowledge and agree that the Related Persons are intended third-party beneficiaries
of this Section 5.16. Nothing in this Agreement precludes the Parties or any Related Persons from exercising any rights under the Merger Agreement or any other agreement to which they are specifically a party or an express
third-party beneficiary thereof, and nothing in this Agreement shall limit the liability or obligations of any Related Person under any other agreement to which they are specifically a party. 

[Signature Page Follows] 

  
 8 

 IN WITNESS WHEREOF, each of the undersigned Parties has executed this Agreement on the date
set forth in the introductory clause above. 
  

			
	ALBERTSONS COMPANIES, INC.
		
	By:	 	 /s/ Juliette Pryor

	Name:	 	Juliette Pryor
	Title:	 	EVP and General Counsel

  

			
	CERBERUS ICEBERG LLC
		
	By:	 	 CERBERUS PARTNERS, L.P.,
 its
Management Member

		
	By:	 	 CERBERUS ASSOCIATES, L.L.C.,
 its
General Partner

	
	 By: /s/ Alexander D. Benjamin

	
	 Alexander D. Benjamin

	Name
	
	 Authorized Signatory

	Title

 [SIGNATURE PAGE TO VOTING
AGREEMENT]Exhibit 10.2

 

HEALTHLYNKED CORP.

NON-DISCLOSURE, NON-SOLICITATION AND NON-COMPETE
AGREEMENT

 

THIS NONDISCLOSURE, NON-SOLICITATION
AND NON-COMPETE AGREEMENT (the “Agreement”) is made and entered into to be effective as of September 20,
2022, by and between George O’Leary (the “Executive”) and HealthLynked Corp. (the “Company”).

 

RECITALS

 

WHEREAS, the Company
desires to employ Executive on the terms and conditions set forth in the Employment Agreement (the “Employment Agreement”),
attached hereto as Exhibit A; and

 

WHEREAS, the Company
desires to secure Executive’s employment as its Chief Financial Officer (“CFO”) from July 1, 2022 through
June 30, 2026 (the “Term of Employment”);

 

WHEREAS, the Company
is engaged in the business of digital healthcare by developing unique cloud-based patient information network and record achieving solutions
in the United States (collectively the “Business”); and

 

WHEREAS, the Company
has developed and will develop relationships with customers, prospective customers, vendors and suppliers as well as a reputation in the
healthcare industry, which are and will become of great importance and value to the Company in connection with the Business, and the loss
of or injury to the Business will result in substantial and irreparable damage to the Company; and

 

WHEREAS, in the course
of Executive’s employment by the Company, Executive may receive, be taught or otherwise have access to items and information associated
with the Business such as business and strategic plans, financial records, customer, vendor and supplier information, inventions, programs,
formulas, trade secrets, techniques, processes, sales and marketing information, pricing information, and other information which is confidential
and proprietary; and

 

WHEREAS, the Company
has acquired and/or developed certain trade secrets and Confidential Information, as more fully described below, and has expended significant
time and expense in acquiring or developing its trade secret or Confidential Information; and expends significant time and expense on
an ongoing basis in supporting its Executives, including the Executive; and

 

WHEREAS, as a condition
of employment, the Executive agrees to comply fully with the terms of this Agreement and all policies and procedures in effect for employees,
including but not limited to, all terms and conditions set forth in the Company’s employee handbook, any code of conduct, any restrictive
covenant policies and any other memoranda and communications applicable to Executive pertaining to the Company’s policies and procedures;
and

 

    1

     

    

 

NOW, THEREFORE, in
consideration of the mutual promises, covenants and agreements contained herein, and intending to be legally bound hereby, the Company
and Executive do hereby agree as follows:

 

AGREEMENT

 

1. Adoption
of Recitals. Executive adopts the above recitals as being true and correct.

 

2. Definitions.

 

(a) For
purposes of this Agreement, the term “Confidential Information” shall mean (i) any information regarding (A)
Customer lists and prospective Customer lists; specific information on Customers and prospective Customers (including information
on preferences, credit information, and pricing); (B) marketing strategies, programs, plans and methods; (C) pricing policies, product
strategies and methods of operation and other business methods; (D) customer lists, customer identification, customer prospects and other
basic customer information; (E) customer credit and pricing information; (F) expansion plans and other business policies and strategies;
(G) business forecasts, financial data, costs, sales and revenue reports, and any analyses not publicly disclosed; (H) confidential information
about employees and other representatives of Company; (I) other information which enables Company to compete successfully; terms and conditions
under which the Company deals with Vendors and supplier or prospective Vendors or suppliers; (J) the Company’s billing rates, pricing
lists (including item and Customer specific pricing information); (K) trade secrets; license agreements; proprietary sales and utilization
methods and techniques; (L) proprietary compositions, ideas and improvements; pricing methods and strategies; (M) utilization methods
and strategies; (N) computer programs, computer systems, computer data, system documentation, special hardware, product hardware, related
software development and computer software design and/or improvements; (O) market feasibility studies; (P) proposed or existing marketing
techniques or plans; (Q) sales and sales volumes; (R) documentation, marketing and business needs of Customers, potential Customers and/or
Vendors; (S) inventions; (T) future Company business plans; project files; design systems; (U) information on current and potential Vendors
including, but not limited to, their identity, pricing, and purchasing information not generally known; (V) personal information about
the Company’s employees, officers and directors; (W) correspondence, and letters, notes, notebooks, reports, flowcharts, proposals,
processes and/or any and/or (X) all other confidential or proprietary information belonging to the Company or relating to the Company’s
business and/or affairs; and (ii) any information that is of value or significance to Company that derives independent economic value,
actual or potential, from not being generally known to, and not being readily ascertainable by proper means by, other persons who can
obtain economic value from its disclosure or use, including information not generally known to the competitors of Company nor intended
by Company for general dissemination. Confidential Information shall not include any (a) information known generally to the public (other
than as a result of unauthorized disclosure by Executive), (b) information that became available from a third party source and such source
is not bound by a confidentiality agreement, or (c) any information not otherwise considered by the Company to be Confidential Information.

 

    2

     

    

 

(b) The
term “Customer” shall mean any person or entity, which has conducted business with the Company or entered into
any contract with the Company, within the one (1) year immediately preceding the termination of the Executive’s employment with
the Company for whatever reason.

 

(a) The
phrase “directly or indirectly” shall include the Executive either on his/her own account, or as a partner,
owner, promoter, joint venturer, Executive, agent, consultant, advisor, manager, Executive, independent contractor, officer, director,
stockholder, or otherwise, of an entity. The Company acknowledges that Executive has been for the last eight years and is currently Vice
Chairman of Referrizer, LLC, a private marketing automation company that does not compete with the Company. For the avoidance of any doubt,
Referrizer, LLC is excluded from any non-compete with the Company as long as it does not directly compete with the Company in the digital
healthcare sector.

 

(b) The
term “Non-Compete Period” shall mean during the Executive’s Term of Employment with the Company and the
twenty-four (24) months immediately following termination of the Executive’s employment with the Company for cause, Executive’s
termination of employment, and end of the contract term. If Company terminates Executive without cause, the non-compete is limited to
six months, as long as the terms of his employment agreement regarding severance is being met.

 

(c) .

 

(d) The
term “Person” shall mean any individual, corporation, association, partnership (general or limited), joint venture,
trust, estate, limited liability company, or other legal entity or organization.

 

(e) The
term “Restricted Area” shall include any geographical location anywhere in the world where the Executive has
been assigned to performed services on behalf of the Company during the Executive’s Term of Employment with the Company and where
the Company, its affiliates or subsidiaries either (a) are engaged in business, and/or (b) have evidenced an intention to
engage in business.

 

(f) The
term “Restricted Business” shall mean any business that competes with the Business of the Company, as such business
now exists (and is defined above in the Recitals) or may exist at the time of the termination of the Executive’s employment with
the Company for cause, Executive’s termination of employment, and end of the contract term. If Company terminates Executive without
cause, the non-compete is limited to six months as long as the terms of his employment agreement regarding severance is being met.

 

(c) The
term “Prospective Customer” shall mean any person or entity, which has evidenced an intention to conduct business
with the Company or evidenced an intention to enter into any contract with the Company, within the one (1) year immediately preceding
the termination of the Executive’s employment with the Company for whatever reason.

 

    3

     

    

 

(g) The
term “Vendor” shall mean any supplier, person or entity from which the Company has purchased products or services
during the one (1) year immediately preceding the termination of the Executive’s employment with the Company for whatever reason.

 

2. Non-Competition.
As a material inducement to the Company to allow the Executive to remain an Executive of the Company, the Executive agrees that, during
the Non-Compete Period, in the Restricted Area, the Executive shall not, directly or indirectly, engage in, promote, finance, own, operate,
develop, sell or manage or assist in or carry on in any Restricted Business; provided, however, that Executive may at any time
own securities of any competitor corporation whose securities are publicly traded on a recognized exchange so long as the aggregate holdings
of the Executive in any one such corporation shall constitute not more than 5% of the voting stock of such corporation.

 

3. Non-Solicitation
of Employees or Independent Contractors. As a material inducement to the Company to allow the Executive to remain an Executive
of the Company, the Executive agrees that, during the Non-Compete Period, Executive shall not directly or indirectly, solicit or attempt
to induce any employee of Company or independent contractor engaged and/or utilized by Company in any capacity to terminate his/her employment
with, or engagement by, Company. Likewise, during the Non-Compete Period, Executive shall not, directly or indirectly, hire or attempt
to hire for another entity or person any employee of Company or independent contractor engaged and/or utilized by Company in any capacity.
David Dodge “DD” whom Executive has a 20+ year business relationship with long before Company was established, is excluded
from this clause, except that Executive will do everything in his control, to have DD continue providing his independent contractor services
with the Company.

 

4. Non-Solicitation
of Customers, Prospective Customers and Vendors. As a material inducement to the Company to allow the Executive to remain an Executive
of the Company, the Executive agrees that, during the Non-Compete Period, the Executive shall not, directly or indirectly sell, market,
assemble, manufacture or distribute any of the Company’s products or services of the type developed, sold or distributed by the
Company to any Customer, Prospective Customer or Vendor of the Company personally or through any entity other than the Company. The Executive
acknowledges and agrees that the Company has substantial relationships with its Customers, Vendors and Prospective Customers, which the
Company expends significant time and resources in acquiring and maintaining, and that the Company has Confidential Information pertaining
to its business and to its Customers, Prospective Customers and Vendors, and that the Company’s Confidential Information and relationships
with its Customers, Prospective Customers and Vendors constitute significant and valuable assets of the Company.

 

    4

     

    

 

5. Non-Disclosure
of Confidential Information of the Company. As a material inducement to the Company to allow the Executive to remain an Executive
of the Company, and as a material inducement to the Company to disclose or allow to be known to the Executive some or all of the Confidential
Information during the term of the Executive’s employment with the Company (at the Company’s sole and absolute discretion),
the Executive hereby agrees that, during and after the Executive’s Term of Employment with the Company, Executive agrees to use
Confidential Information only in the course and scope of Executive’s employment by the Company and for the exclusive benefit of
the Company. Except for disclosure in the course and scope of Executive’s employment by the Company and on behalf of the Company,
Executive will never at any time, either during or after employment by the Company, directly or indirectly, use, publish, disseminate,
distribute or otherwise disclose any Confidential Information to any other person or entity. Executive agrees to take all steps necessary,
and all steps requested by the Company, to ensure that the Confidential Information is kept secret and confidential and for the sole use
and benefit of the Company and to comply with all applicable policies and procedures of the Company regarding the storage and security
of all Confidential Information whether in hard copy form or stored on computer disks or other electronic media. Such policies and procedures
may include, but not be limited to, a prohibition against Executive sending any Company document to a personal e-mail account or using
any removable media, such as a flash or external drive, at Executive’s work station, absent explicit written permission from the
CEO. If the Executive is requested or legally required to disclose any Confidential Information or trade secrets, the Executive must notify
the Company prior to doing so by providing the Company with written notice ten (10) business days in advance of the intended or compelled
disclosure. (If disclosure is required sooner than ten (10) days, the Executive must provide the Company with Notice immediately upon
learning that disclosure is sought and before disclosure is required or compelled). Notice shall be provided to the following
address: HealthLynked Corporation, 1265 Creekside Pkwy, Suite 302, Naples, FL 34108

 

6. Notice
of Immunity under the Economic Espionage Act of 1996, as amended by the Defend Trade Secrets Act of 2016 (“DTSA”).
Notwithstanding any other provision of this Agreement, the Executive shall not be held criminally or civilly liable under any federal
or state trade secret law for any disclosure of a trade secret that: (a) is made: (1) in confidence to a federal, state, or local government
official, either directly or indirectly, or to an attorney; and (2) solely for the purpose of reporting or investigating a suspected violation
of law; or (b) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. Notwithstanding any
other provision of this Agreement, if the Executive files a lawsuit for retaliation by the Company for reporting a suspected violation
of law, the Executive may disclose the Company’s trade secrets to the Executive’s attorney and use the trade secret information
in the court proceeding if the Executive: (x) files any document containing the trade secret under seal; and (y) does not disclose the
trade secret, except pursuant to court order.

 

7. Need
for Restrictions. Executive acknowledges and agrees that each of the restrictive covenants contained in this Agreement is reasonable
and necessary to protect the legitimate business interests of Company, including, without limitation, the need to protect Company’s
trade secrets and Confidential Information and the need to protect its relationships with its Customers, Prospective Customers, and Vendors.
Executive also acknowledges and agrees, as set forth in Section 9 below, that Company may obtain a temporary, preliminary and/or permanent
injunction to restrain any violations of, or otherwise enforce, the restrictive covenants contained in this Agreement. Executive also
acknowledges and agrees that, if his/her future employment’s job duties would inevitably cause him/her to disclose Confidential
Information or trade secrets of Company, Company may seek to protect its legitimate business interests by enjoining him/her from working
in that future position.

 

    5

     

    

 

8. Proprietary
Rights.

 

(a) Ownership.
The Company shall own all right, title and interest in and to all documentation, manuals, materials, creative works, methods, techniques,
compositions, ideas, recipes, creations, improvements, inventions, computer programs and data, system documentation, special hardware,
product hardware, related software development, correspondence, letters, notes, notebooks, reports, flowcharts, proposals, know-how and
other information, in any medium whatsoever (including, without limitation, any Confidential Information, trade secrets and all software,
software code, processes, copyrights, patents, technologies and inventions (collectively, “Inventions”), including,
without limitation, new contributions, improvements, ideas and discoveries, whether patentable or not, conceived, developed, invented
or made by the Executive during his/her employment by the Company (including his/her employment with the Company prior to the date hereof),
provided that such Inventions grew out of the Executive’s work with the Company, are related in any manner to the Business, as such
term is defined in the Recitals, or are conceived or made on the Company’s time or with the use of the Company’s facilities
or materials). Executive acknowledges and agrees that any of his/her work product created, produced or conceived in connection with his/her
association with the Company shall be deemed work for hire and shall be deemed owned exclusively by the Company.

 

(b)  Executive’s
Obligations. Executive shall (i) promptly disclose such Inventions to the Company (ii) assign to the Company,
without additional compensation, all patent and other rights to such Inventions for the United States and foreign countries;
(iii) execute and deliver all documents required by the Company to document or perfect the Company’s proprietary rights
in and to the Company’s work product; and (iv) give testimony in support of his/her inventorship. Executive shall deliver
all Confidential Information, trade secrets and/or Inventions to the Company upon the Company’s request, and, in any event,
immediately upon termination of the Executive’s employment by the Company.

 

(c) Executive’s
Restrictions. Executive acknowledges that the Confidential Information, trade secrets and/or Inventions constitute valuable trade
secrets of the Company. Executive shall not infringe or violate any trade secret or other proprietary right of the Company related to
the Confidential Information, trade secrets and/or Inventions, and shall not own, apply for or otherwise attempt to obtain, on behalf
of Executive or others, any proprietary right in any Confidential Information, trade secrets and/or Inventions, which the Company owns
or has a right to own, in which the Company has an interest and/or to which the Company has title.

 

9. Breach
of Restrictive Covenants. Executive understands that if he/she violates the terms of this Agreement while employed by the Company,
Executive will be subject to disciplinary action up to and including discharge from employment. Executive acknowledges and agrees that
Confidential Information is a special and unique asset of the Company and derives independent economic value, actual or potential, from
not being generally known by the public or by other persons or entities who can obtain economic value from its disclosure. Executive further
agrees and acknowledges that improper disclosure of the Company’s Confidential Information and the breach of any other restrictive
set forth this Agreement would cause irreparable injury to the Company, and that, if the Company shall bring legal proceedings against
Executive to enforce any restrictive covenant, the Company shall be entitled to seek all available civil remedies, at law or in equity,
including, without limitation, an injunction without posting a bond, damages, attorneys’ fees, and costs.

 

    6

     

    

 

10. Return
of the Company’s Property. All of the Company’s Customer correspondence, internal memoranda, designs, sales brochures,
training manuals, project files, price lists, Customer and Vendor lists, prospectus reports, Customer or Vendor information, sales literature,
territory printouts, call books, notebooks, textbooks e-mails and Internet access, and all other like information or products, including
all copies, duplications, replications and derivatives of such information or products, acquired by the Executive while in the employ
of the Company, whether prepared by the Executive or coming into the Executive’s possession, shall be the exclusive property of
the Company and shall be returned immediately to the Company upon the expiration or termination of this Agreement for any reason or upon
request by the President or Chief Executive Officer. The Executive also shall return immediately return any Company issued property including,
but not limited to, laptops, computers, thumb drives, removable media devices, flash drives, smartphones, cellular phones, iPads and other
devices upon the expiration or termination of this Agreement for any reason. The Executive’s obligations under this Section 10
shall exist whether or not any of these items or materials contain Confidential Information or trade secrets.

 

11. Prior
Agreements and Indemnification. Executive represents to the Company: (a) that there are no restrictions, agreements, or understandings
whatsoever to which the Executive is a party which would prevent or make unlawful the Executive’s execution of this Agreement or
employment hereunder, (b) that the Executive’s execution of this Agreement and employment hereunder shall not constitute a breach
of any contract, agreement or understanding, oral or written, to which the Executive is a party or by which the Executive is bound, and
(c) that the Executive is free and able to execute this Agreement and to enter into the Term of Employment with the Company. The Executive
further represents and agrees that he/she will not bring with him/her, disclose or otherwise use any confidential, proprietary or trade
secret information acquired from any prior employer, whether that information was created by the Executive or others. A written or oral
notice or complaint that Executive breached this provision or violated a restrictive covenant or an agreement not to disclose confidential
information shall subject the Executive, at the Company’s sole discretion, to immediate termination, including a termination for
Cause, to the extent applicable. Executive also agrees to fully indemnify the Company for any and all damages, costs and/or attorney’s
fees incurred by the Company that arise from any claims that were related to the Executive’s alleged or actual breach of a restrictive
covenant or an agreement not to disclose confidential information.

 

12.
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the Company and its successors
and assigns, and the Executive agrees that this Agreement may be assigned by the Company without the Executive’s consent. This Agreement
is not assignable by the Executive.

 

13. Construction,
Survival. If the period of time, area, or scope of restriction specified in this Agreement should be adjudged unreasonable in
any proceeding, then the period of time, area, or scope shall be reduced so that the restrictions may be enforced as is adjudged to be
reasonable. If the Executive violates any of the restrictions contained in this Agreement, the restrictive period shall be tolled during
the time that the Executive is in violation. All the provisions of this Agreement shall survive Executive’s employment with the
Company.

 

    7

     

    

 

14. Modification/Entire
Agreement/Amendments. No provision of this Agreement may be modified, waived or discharged unless such waiver, modification or
discharge is approved by the Company and agreed to in writing signed by Executive and such officer as may be specifically authorized by
the Company. This Agreement contains the entire understanding of the parties hereto, and no agreements or representations, oral or otherwise,
express or implied, with respect to the subject matter hereof have been made by either party, which are not set forth expressly in this
Agreement. This Agreement supersedes all negotiations, preliminary agreements, and all prior and contemporaneous discussions and understandings
of the parties hereto and/or their affiliates. The Executive acknowledges that he/she has not relied on any prior or contemporaneous discussions
or understandings in entering into this Agreement.

 

15. Waiver.
The waiver by any party of any breach of any provision of this Agreement shall not be construed as a waiver of any subsequent breach of
such provision or the breach of any other provision contained in this Agreement.

 

16. Supersedes. This
Agreement supersedes and replaces all prior restrictive covenants, contracts or agreements between the Executive and the Company. The
Executive acknowledges that the Term of Employment with the Company sufficient consideration for entering into this new Agreement.

 

17. Right
to Review and Seek Counsel. The Executive acknowledges that he/she has had the opportunity to seek independent counsel and tax
advice in connection with the execution of this Agreement, and the Executive represents and warrants to the Company (a) that he/she has
sought such independent counsel and advice as he/she has deemed appropriate in connection with the execution hereof and the transactions
contemplated hereby, and (b) that he/she has not relied on any representation of the Company as to tax matters, or as to the consequences
of the execution hereof.

 

18. Headings
and Captions. The titles and captions of paragraphs and subparagraphs contained in this Agreement are provided for convenience
of reference only and shall not be considered terms or conditions of this Agreement.

 

19. Governing
Law. This Agreement shall be governed and construed in accordance with the laws of the State of Florida without regard to conflicts
of law.

 

20. Validity.
The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision
of this Agreement, which shall remain in full force and effect.

 

    8

     

    

 

21. Consent
to Personal Jurisdiction and Venue; Waiver of Jury Trial; Waiver of Service of Process. The Executive hereby consents to personal
jurisdiction and exclusive venue in the United States District Court for the Middle District of Florida, if such Court can exercise jurisdiction
over the matter for any action brought by the Company or the Executive arising out of or in connection with this Agreement or the Executive’s
employment with the Company. In the event the foregoing Court lacks jurisdiction, the Executive consents to personal jurisdiction and
exclusive venue in the Circuit Court in and for Collier County, Florida. Furthermore, the Executive
and Company hereby expressly waive a trial by jury in any action between the Executive and the Company arising out of or in connection
with this Agreement. For purposes of this Section, the term “Executive” includes any business entity owned or controlled
by the Executive. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy thereof to such party at the address listed herein and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any manner permitted by law. Notice shall be provided to the following address: To Company: HealthLynked Corporation, 1265
Creekside Pkwy, Suite 302, Naples, FL 34108. To Executive: 9800 Quaye Side Drive, Unit 105 Wellington FL 33411

 

22. Counterparts.
This Agreement may be executed in one or more separate counterparts, each of which, when so executed, shall be deemed to be an original.
Such counterparts shall together constitute and shall be one and the same instrument. This Agreement, and the counterparts thereto, may
be executed by the Parties using their respective signatures transmitted by via electronic mail.

 

	EXECUTIVE:	 	WITNESS:	 
	 	 	 	 
	/s/ George O’Leary	 	/s/ Michael Dent, M.D. 	 
	George O’Leary	 	Michael Dent, M.D.	 
	 	 	Chairman and CEO	 
	 	 	 	 
	Dated: 9.26.22	 	Dated: 10/13/2022	 

 

 

9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}]]